We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. Relay Therapeutics, Inc. (NASDAQ:RLAY) is the ...
Relay shares had been under pressure since October when initial results from VIKTORIA-1’s wild-type cohort exceeded market expectations. However, Oppenheimer believes replicating that success in ...
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the stocks that will double in 2026. On December 9, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Gossamer Bio, with a price target of $15.
According to the company, the committee said that the safety concerns warrant reevaluation of the study design, particularly ...